A199730 Share Price Performance
₩0
-7130.00 (-100.00%)
Price ₩0
Share Pricen/a
No recently updated narratives available.
Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. Its primary product is a bioequivalence test for generic drugs, a phase 1 test for incrementally modified drugs; and a phase 1 sample analysis for other new substances. The company was founded in 2007 and is based in Yongin-si, South Korea.